𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sequential studies on the role of mitoxantrone in the treatment of acute leukaemia

✍ Scribed by H. G. Prentice; J. Z. Wimperis; G. Robbins


Publisher
Springer US
Year
1985
Tongue
English
Weight
368 KB
Volume
3
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Hepatotoxicity in the treatment of acute
✍ Topley, J. M. ;Benson, J. ;Squier, M. V. ;Chessells, J. M. πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 368 KB

Serial liver function tests and percutaneous liver biopsies were performed on 21 children receiving treatment for acute lymphoblastic leukaemia (ALL). The patients received continuing chemotherapy either with daily 6-mercaptopurine and weekly methotrexate or with five-day pulses of these drugs every

Mitoxantrone in the treatment of relapse
✍ P. Meyer; A. D. Ho; G. Ehninger; I. Mjaaland; E. Heidemann; E. Seither πŸ“‚ Article πŸ“… 1985 πŸ› Springer US 🌐 English βš– 245 KB

Twenty-four patients with acute leukemia or blast crisis (BC) of chronic myelocytic leukemia (CML) in relapse or refractory to standard chemotherapy, were eligible for treatment with mitoxantrone. Mitoxantrone (Novantrone| dihydroxyanthracenedione) was administered in a dose of 8-13 mg/m 2 on five c

Clofarabine in the treatment of poor ris
✍ Janusz Krawczyk; Naeem Ansar; Ronan Swords; Tracy Murphy; Barry MacDonagh; Teres πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 92 KB

## Abstract Clofarabine is a second generation nucleoside analogue. It inhibits DNA repair and activates the mitochondrial apoptotic pathway leading to cell death. __In vitro__ clofarabine has demonstrated synergy with daunorubicin and Ara‐C and in phase II clinical trials has shown promising activ